Chronic pulmonary insufficiency of prematurity: developing optimal endpoints for drug development

R Steinhorn, JM Davis, W Göpel, A Jobe… - The journal of …, 2017 - jpeds.com
Chronic pulmonary insufficiency is the most common health morbidity of extremely preterm
birth. It is associated with increased resource utilization during the initial hospitalization, as …

Outpatient respiratory management of infants, children, and adolescents with post-prematurity respiratory disease: an official American Thoracic Society clinical …

AI Cristea, CL Ren, R Amin, LC Eldredge… - American journal of …, 2021 - atsjournals.org
Background: Premature birth affects millions of neonates each year, placing them at risk for
respiratory disease due to prematurity. Bronchopulmonary dysplasia is the most common …

Interdisciplinary care of children with severe bronchopulmonary dysplasia

SH Abman, JM Collaco, EG Shepherd… - The Journal of …, 2017 - jpeds.com
Advances in perinatal care have dramatically im-proved survival of extremely preterm infants
and the incidence of bronchopulmonary dysplasia (BPD) has not changed over the past few …

[HTML][HTML] Pharmacotherapy in bronchopulmonary dysplasia: what is the evidence?

RP Sakaria, R Dhanireddy - Frontiers in Pediatrics, 2022 - frontiersin.org
Bronchopulmonary Dysplasia (BPD) is a multifactorial disease affecting over 35% of
extremely preterm infants born each year. Despite the advances made in understanding the …

Lung function outcome in children of premature birth

JD Kennedy - Journal of paediatrics and child health, 1999 - Wiley Online Library
Since the 1960s there has been a continual improvement in the survival of premature infants
of birthweight less than 1500 g. This has resulted in an increase in the prevalence of …

Pulmonary hypertension in chronic lung disease of infancy: pathogenesis, pathophysiology, and treatment

SH Abman - Chronic lung disease in early infancy, 1999 - taylorfrancis.com
Nearly 30 years have passed since Northway and his colleagues provided the first clinical,
radiologic, and pathological description of the chronic lung disease known as …

[HTML][HTML] Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the …

GS Pryhuber, NL Maitre, RA Ballard, D Cifelli, SD Davis… - BMC pediatrics, 2015 - Springer
Background With improved survival rates, short-and long-term respiratory complications of
premature birth are increasing, adding significantly to financial and health burdens in the …

Respiratory medication use in extremely premature (< 29 weeks) infants during initial NICU hospitalization: results from the prematurity and respiratory outcomes …

JM Greenberg, BB Poindexter, PA Shaw… - Pediatric …, 2020 - Wiley Online Library
Background The use of medications to treat respiratory conditions of extreme prematurity is
often based upon studies of adults or children over 2 years of age. Little is known about the …

[HTML][HTML] Drug therapy for the prevention and treatment of bronchopulmonary dysplasia

A Iyengar, JM Davis - Frontiers in pharmacology, 2015 - frontiersin.org
Introduction: As more infants are surviving at younger gestational ages, bronchopulmonary
dysplasia (BPD) remains as a frequent neonatal complication occurring after preterm birth …

Bronchopulmonary dysplasia: an update of current pharmacologic therapies and new approaches

Z Michael, F Spyropoulos, S Ghanta… - Clinical Medicine …, 2018 - journals.sagepub.com
Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of
surviving extremely preterm infants and is associated with significant health care utilization …